Novartis PREVENT data show Cosentyx® helps patients realize early and lasting relief in axial spondyloarthritis

    NEXT STORY
    Tiziana Life Sciences announces that its Scientific Advisory Board Chairman Dr. Howard Weiner received NIH grant to investigate Nasal Anti-CD3 for the treatment of Alzheimer’s disease
    PREV STORY
    FILGOTINIB DEMONSTRATES DURABLE EFFICACY AND CONSISTENT SAFETY PROFILE AT 52 WEEKS IN FINCH 1 AND 3 STUDIES IN RHEUMATOID ARTHRITIS
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit

    PHILADELPHIA and OXFORD, United Kingdom, March 27, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...

    author_avatar
    NASDAQ Market News

    Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    DUBLIN, Ireland, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome

    LONDON and CARLSBAD, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ...

    author_avatar
    NASDAQ Market News